Nuclear proteins acting on mitochondria

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 4, 2011, Pages 584-596

  Lindenboim, Liora ^a   Borner, Christoph ^b   Stein, Reuven ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Bak; Bax; Mitochondria; Nuclear proteins; Protein translocation

Indexed keywords

HISTONE H1; NUCLEAR PROTEIN; NUCLEAR RECEPTOR NUR77; NUCLEOPHOSMIN; PROTEIN BAK; PROTEIN BAX; PROTEIN P53;

APOPTOSIS; CYTOSOL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; HUMANS; MITOCHONDRIA; NUCLEAR PROTEINS;

EID: 79952706481     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.11.016     Document Type: Review

References (184)

1. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9:47-59.
2. Wang C., Youle R.J. The role of mitochondria in apoptosis. Annu. Rev. Genet. 2009, 43:95-118.
3. Vaux D.L. Apoptogenic factors released from mitochondria. Biochim. Biophys. Acta 2011, 1813:546-550.
4. Lindenboim L., Blacher E., Borner C., Stein R. Regulation of stress-induced nuclear protein redistribution: a new function of Bax and Bak uncoupled from Bcl-x(L). Cell Death Differ. 2010, 17:346-359.
5. Geng Y., Walls K.C., Ghosh A.P., Akhtar R.S., Klocke B.J., Roth K.A. Cytoplasmic p53 and activated Bax regulate p53-dependent, transcription-independent neural precursor cell apoptosis. J. Histochem. Cytochem. 2010, 58:265-275.
6. Ferrando-May E., Cordes V., Biller-Ckovric I., Mirkovic J., Gorlich D., Nicotera P. Caspases mediate nucleoporin cleavage, but not early redistribution of nuclear transport factors and modulation of nuclear permeability in apoptosis. Cell Death Differ. 2001, 8:495-505.
7. Faleiro L., Lazebnik Y. Caspases disrupt the nuclear-cytoplasmic barrier. J. Cell Biol. 2000, 151:951-959.
8. Ferrando-May E. Nucleocytoplasmic transport in apoptosis. Cell Death Differ. 2005, 12:1263-1276.
9. Grote P., Schaeuble K., Ferrando-May E. Commuting (to) suicide: an update on nucleocytoplasmic transport in apoptosis. Arch. Biochem. Biophys. 2007, 462:156-161.
10. Moll U.M., Marchenko N., Zhang X.K. p53 and Nur77/TR3-transcription factors that directly target mitochondria for cell death induction. Oncogene 2006, 25:4725-4743.
11. Tembe V., Henderson B.R. Protein trafficking in response to DNA damage. Cell. Signal. 2007, 19:1113-1120.
12. Speidel D. Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol. 2010, 20:14-24.
13. Vaseva A.V., Moll U.M. The mitochondrial p53 pathway. Biochim. Biophys. Acta 2009, 1787:414-420.
14. Vousden K.H., Prives C. Blinded by the light: the growing complexity of p53. Cell 2009, 137:413-431.
15. Laptenko O., Prives C. Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ. 2006, 13:951-961.
16. Haupt Y., Rowan S., Shaulian E., Vousden K.H., Oren M. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev. 1995, 9:2170-2183.
17. Kakudo Y., Shibata H., Otsuka K., Kato S., Ishioka C. Lack of correlation between p53-dependent transcriptional activity and the ability to induce apoptosis among 179 mutant p53s. Cancer Res. 2005, 65:2108-2114.
18. Caelles C., Helmberg A., Karin M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 1994, 370:220-223.
19. Chipuk J.E., Maurer U., Green D.R., Schuler M. Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell 2003, 4:371-381.
20. Johnson T.M., Meade K., Pathak N., Marques M.R., Attardi L.D. Knockin mice expressing a chimeric p53 protein reveal mechanistic differences in how p53 triggers apoptosis and senescence. Proc. Natl Acad. Sci. USA 2008, 105:1215-1220.
21. Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., Moll U.M. p53 has a direct apoptogenic role at the mitochondria. Mol. Cell 2003, 11:577-590.
22. Leu J.I., Dumont P., Hafey M., Murphy M.E., George D.L. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat. Cell Biol. 2004, 6:443-450.
23. Chipuk J.E., Kuwana T., Bouchier-Hayes L., Droin N.M., Newmeyer D.D., Schuler M., Green D.R. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004, 303:1010-1014.
24. Marchenko N.D., Moll U.M. The role of ubiquitination in the direct mitochondrial death program of p53. Cell Cycle 2007, 6:1718-1723.
25. Dumont P., Leu J.I., Della Pietra A.C., George D.L., Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 2003, 33:357-365.
26. Sansome C., Zaika A., Marchenko N.D., Moll U.M. Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells. FEBS Lett. 2001, 488:110-115.
27. Akhtar R.S., Geng Y., Klocke B.J., Roth K.A. Neural precursor cells possess multiple p53-dependent apoptotic pathways. Cell Death Differ. 2006, 13:1727-1739.
28. Arima Y., Nitta M., Kuninaka S., Zhang D., Fujiwara T., Taya Y., Nakao M., Saya H. Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria. J. Biol. Chem. 2005, 280:19166-19176.
29. Erster S., Mihara M., Kim R.H., Petrenko O., Moll U.M. In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol. Cell. Biol. 2004, 24:6728-6741.
30. Geng Y., Akhtar R.S., Shacka J.J., Klocke B.J., Zhang J., Chen X., Roth K.A. p53 transcription-dependent and -independent regulation of cerebellar neural precursor cell apoptosis. J. Neuropathol. Exp. Neurol. 2007, 66:66-74.
31. Kojima K., Konopleva M., McQueen T., O'Brien S., Plunkett W., Andreeff M. Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia. Blood 2006, 108:993-1000.
32. Mahyar-Roemer M., Fritzsche C., Wagner S., Laue M., Roemer K. Mitochondrial p53 levels parallel total p53 levels independent of stress response in human colorectal carcinoma and glioblastoma cells. Oncogene 2004, 23:6226-6236.
33. Nair V.D., McNaught K.S., Gonzalez-Maeso J., Sealfon S.C., Olanow C.W. p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition. J. Biol. Chem. 2006, 281:39550-39560.
34. Qin H., Yu T., Qing T., Liu Y., Zhao Y., Cai J., Li J., Song Z., Qu X., Zhou P., Wu J., Ding M., Deng H. Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J. Biol. Chem. 2007, 282:5842-5852.
35. Speidel D., Helmbold H., Deppert W. Dissection of transcriptional and non-transcriptional p53 activities in the response to genotoxic stress. Oncogene 2006, 25:940-953.
36. Steele A.J., Prentice A.G., Hoffbrand A.V., Yogashangary B.C., Hart S.M., Nacheva E.P., Howard-Reeves J.D., Duke V.M., Kottaridis P.D., Cwynarski K., Vassilev L.T., Wickremasinghe R.G. p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism. Blood 2008, 112:3827-3834.
37. Strom E., Sathe S., Komarov P.G., Chernova O.B., Pavlovska I., Shyshynova I., Bosykh D.A., Burdelya L.G., Macklis R.M., Skaliter R., Komarova E.A., Gudkov A.V. Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat. Chem. Biol. 2006, 2:474-479.
38. Todorovicc V., Chen C.C., Hay N., Lau L.F. The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts. J. Cell Biol. 2005, 171:559-568.
39. Waster P.K., Ollinger K.M. Redox-dependent translocation of p53 to mitochondria or nucleus in human melanocytes after UVA- and UVB-induced apoptosis. J. Invest. Dermatol. 2009, 129:1769-1781.
40. Kojima K., Konopleva M., Samudio I.J., Shikami M., Cabreira-Hansen M., McQueen T., Ruvolo V., Tsao T., Zeng Z., Vassilev L.T., Andreeff M. MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy. Blood 2005, 106:3150-3159.
41. Nemajerova A., Wolff S., Petrenko O., Moll U.M. Viral and cellular oncogenes induce rapid mitochondrial translocation of p53 in primary epithelial and endothelial cells early in apoptosis. FEBS Lett. 2005, 579:6079-6083.
42. Zhao Y., Chaiswing L., Velez J.M., Batinic-Haberle I., Colburn N.H., Oberley T.D., St Clair D.K. p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res. 2005, 65:3745-3750.
43. Endo H., Kamada H., Nito C., Nishi T., Chan P.H. Mitochondrial translocation of p53 mediates release of cytochrome c and hippocampal CA1 neuronal death after transient global cerebral ischemia in rats. J. Neurosci. 2006, 26:7974-7983.
44. Wolff S., Erster S., Palacios G., Moll U.M. p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity. Cell Res. 2008, 18:733-744.
45. Hosako H., Little S.A., Barrier M., Mirkes P.E. Teratogen-induced activation of p53 in early postimplantation mouse embryos. Toxicol. Sci. 2007, 95:257-269.
46. Bonafe M., Salvioli S., Barbi C., Trapassi C., Tocco F., Storci G., Invidia L., Vannini I., Rossi M., Marzi E., Mishto M., Capri M., Olivieri F., Antonicelli R., Memo M., Uberti D., Nacmias B., Sorbi S., Monti D., Franceschi C. The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death. Cell Death Differ. 2004, 11:962-973.
47. Marchenko N.D., Zaika A., Moll U.M. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J. Biol. Chem. 2000, 275:16202-16212.
48. Essmann F., Pohlmann S., Gillissen B., Daniel P.T., Schulze-Osthoff K., Janicke R.U. Irradiation-induced translocation of p53 to mitochondria in the absence of apoptosis. J. Biol. Chem. 2005, 280:37169-37177.
49. Palacios G., Moll U.M. Mitochondrially targeted wild-type p53 suppresses growth of mutant p53 lymphomas in vivo. Oncogene 2006, 25:6133-6139.
50. Talos F., Petrenko O., Mena P., Moll U.M. Mitochondrially targeted p53 has tumor suppressor activities in vivo. Cancer Res. 2005, 65:9971-9981.
51. Pietsch E.C., Perchiniak E., Canutescu A.A., Wang G., Dunbrack R.L., Murphy M.E. Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain. J. Biol. Chem. 2008, 283:21294-21304.
52. Chipuk J.E., Moldoveanu T., Llambi F., Parsons M.J., Green D.R. The BCL-2 family reunion. Mol. Cell 2010, 37:299-310.
53. Ghiotto F., Fais F., Bruno S. BH3-only proteins: the death-puppeteer's wires. Cytom. A 2010, 77:11-21.
54. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9:47-59.
55. Green D.R., Kroemer G. Cytoplasmic functions of the tumour suppressor p53. Nature 2009, 458:1127-1130.
56. Sot B., Freund S.M., Fersht A.R. Comparative biophysical characterization of p53 with the pro-apoptotic BAK and the anti-apoptotic BCL-xL. J. Biol. Chem. 2007, 282:29193-29200.
57. Tan J., Zhuang L., Leong H.S., Iyer N.G., Liu E.T., Yu Q. Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells. Cancer Res. 2005, 65:9012-9020.
58. Raffo A.J., Kim A.L., Fine R.L. Formation of nuclear Bax/p53 complexes is associated with chemotherapy induced apoptosis. Oncogene 2000, 19:6216-6228.
59. Tomita Y., Marchenko N., Erster S., Nemajerova A., Dehner A., Klein C., Pan H., Kessler H., Pancoska P., Moll U.M. WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J. Biol. Chem. 2006, 281:8600-8606.
60. Petros A.M., Gunasekera A., Xu N., Olejniczak E.T., Fesik S.W. Defining the p53 DNA-binding domain/Bcl-x(L)-binding interface using NMR. FEBS Lett. 2004, 559:171-174.
61. Xu H., Tai J., Ye H., Kang C.B., Yoon H.S. The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl. Biochem. Biophys. Res. Commun. 2006, 341:938-944.
62. Deng X., Gao F., Flagg T., Anderson J., May W.S. Bcl2's flexible loop domain regulates p53 binding and survival. Mol. Cell. Biol. 2006, 26:4421-4434.
63. Hagn F., Klein C., Demmer O., Marchenko N., Vaseva A., Moll U.M., Kessler H. BclxL changes conformation upon binding to wild-type but not mutant p53 DNA binding domain. J. Biol. Chem. 2010, 285:3439-3450.
64. Chipuk J.E., Bouchier-Hayes L., Kuwana T., Newmeyer D.D., Green D.R. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 2005, 309:1732-1735.
65. Liu J., St Clair D.K., Gu X., Zhao Y. Blocking mitochondrial permeability transition prevents p53 mitochondrial translocation during skin tumor promotion. FEBS Lett. 2008, 582:1319-1324.
66. Tasdemir E., Maiuri M.C., Galluzzi L., Vitale I., Djavaheri-Mergny M., D'Amelio M., Criollo A., Morselli E., Zhu C., Harper F., Nannmark U., Samara C., Pinton P., Vicencio J.M., Carnuccio R., Moll U.M., Madeo F., Paterlini-Brechot P., Rizzuto R., Szabadkai G., Pierron G., Blomgren K., Tavernarakis N., Codogno P., Cecconi F., Kroemer G. Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol. 2008, 10:676-687.
67. Morselli E., Tasdemir E., Maiuri M.C., Galluzzi L., Kepp O., Criollo A., Vicencio J.M., Soussi T., Kroemer G. Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle 2008, 7:3056-3061.
68. Merrick B.A., He C., Witcher L.L., Patterson R.M., Reid J.J., Pence-Pawlowski P.M., Selkirk J.K. HSP binding and mitochondrial localization of p53 protein in human HT1080 and mouse C3H10T1/2 cell lines. Biochim. Biophys. Acta 1996, 1297:57-68.
69. Achanta G., Sasaki R., Feng L., Carew J.S., Lu W., Pelicano H., Keating M.J., Huang P. Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma. EMBO J. 2005, 24:3482-3492.
70. de Souza-Pinto N.C., Harris C.C., Bohr V.A. p53 functions in the incorporation step in DNA base excision repair in mouse liver mitochondria. Oncogene 2004, 23:6559-6568.
71. Heyne K., Mannebach S., Wuertz E., Knaup K.X., Mahyar-Roemer M., Roemer K. Identification of a putative p53 binding sequence within the human mitochondrial genome. FEBS Lett. 2004, 578:198-202.
72. Chen D., Yu Z., Zhu Z., Lopez C.D. The p53 pathway promotes efficient mitochondrial DNA base excision repair in colorectal cancer cells. Cancer Res. 2006, 66:3485-3494.
73. Yoshida Y., Izumi H., Torigoe T., Ishiguchi H., Itoh H., Kang D., Kohno K. P53 physically interacts with mitochondrial transcription factor A and differentially regulates binding to damaged DNA. Cancer Res. 2003, 63:3729-3734.
74. Nemajerova A., Erster S., Moll U.M. The post-translational phosphorylation and acetylation modification profile is not the determining factor in targeting endogenous stress-induced p53 to mitochondria. Cell Death Differ. 2005, 12:197-200.
75. Marchenko N.D., Wolff S., Erster S., Becker K., Moll U.M. Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J. 2007, 26:923-934.
76. Jiang P., Du W., Heese K., Wu M. The Bad guy cooperates with good cop p53: Bad is transcriptionally up-regulated by p53 and forms a Bad/p53 complex at the mitochondria to induce apoptosis. Mol. Cell. Biol. 2006, 26:9071-9082.
77. Dhar S.K., St Clair D.K. Nucleophosmin blocks mitochondrial localization of p53 and apoptosis. J. Biol. Chem. 2009, 284:16409-16418.
78. You H., Yamamoto K., Mak T.W. Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a. Proc. Natl Acad. Sci. USA 2006, 103:9051-9056.
79. Hsu H.C., Zhou T., Mountz J.D. Nur77 family of nuclear hormone receptors. Curr. Drug Targets Inflamm. Allergy 2004, 3:413-423.
80. Zhan Y., Du X., Chen H., Liu J., Zhao B., Huang D., Li G., Xu Q., Zhang M., Weimer B.C., Chen D., Cheng Z., Zhang L., Li Q., Li S., Zheng Z., Song S., Huang Y., Ye Z., Su W., Lin S.C., Shen Y., Wu Q. Cytosporone B is an agonist for nuclear orphan receptor Nur77. Nat. Chem. Biol. 2008, 4:548-556.
81. Zhang X.K. Targeting Nur77 translocation. Expert Opin. Ther. Targets 2007, 11:69-79.
82. Rajpal A., Cho Y.A., Yelent B., Koza-Taylor P.H., Li D., Chen E., Whang M., Kang C., Turi T.G., Winoto A. Transcriptional activation of known and novel apoptotic pathways by Nur77 orphan steroid receptor. EMBO J. 2003, 22:6526-6536.
83. Wang A., Rud J., Olson C.M., Anguita J., Osborne B.A. Phosphorylation of Nur77 by the MEK-ERK-RSK cascade induces mitochondrial translocation and apoptosis in T cells. J. Immunol. 2009, 183:3268-3277.
84. Thompson J., Winoto A. During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic BH3 domain. J. Exp. Med. 2008, 205:1029-1036.
85. Chen J., Fiskus W., Eaton K., Fernandez P., Wang Y., Rao R., Lee P., Joshi R., Yang Y., Kolhe R., Balusu R., Chappa P., Natarajan K., Jillella A., Atadja P., Bhalla K.N. Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism. Blood 2009, 113:4038-4048.
86. Lee K.W., Ma L., Yan X., Liu B., Zhang X.K., Cohen P. Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77. J. Biol. Chem. 2005, 280:16942-16948.
87. Maddika S., Booy E.P., Johar D., Gibson S.B., Ghavami S., Los M. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway. J. Cell Sci. 2005, 118:4485-4493.
88. Wilson A.J., Arango D., Mariadason J.M., Heerdt B.G., Augenlicht L.H. TR3/Nur77 in colon cancer cell apoptosis. Cancer Res. 2003, 63:5401-5407.
89. Cao X., Liu W., Lin F., Li H., Kolluri S.K., Lin B., Han Y.H., Dawson M.I., Zhang X.K. Retinoid X receptor regulates Nur77/TR3-dependent apoptosis [corrected] by modulating its nuclear export and mitochondrial targeting. Mol. Cell. Biol. 2004, 24:9705-9725.
90. Liu J., Zhou W., Li S.S., Sun Z., Lin B., Lang Y.Y., He J.Y., Cao X., Yan T., Wang L., Lu J., Han Y.H., Cao Y., Zhang X.K., Zeng J.Z. Modulation of orphan nuclear receptor Nur77-mediated apoptotic pathway by acetylshikonin and analogues. Cancer Res. 2008, 68:8871-8880.
91. Liu D., Jia H., Holmes D.I., Stannard A., Zachary I. Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1. Arterioscler. Thromb. Vasc. Biol. 2003, 23:2002-2007.
92. Yang H., Bushue N., Bu P., Yvonne Wan Y.J. Induction and intracellular localization of Nur77 dictate fenretinide-induced apoptosis of human liver cancer cells. Biochem. Pharmacol. 2010, 79:948-954.
93. Wu Q., Liu S., Ye X.F., Huang Z.W., Su W.J. Dual roles of Nur77 in selective regulation of apoptosis and cell cycle by TPA and ATRA in gastric cancer cells. Carcinogenesis 2002, 23:1583-1592.
94. Li H., Kolluri S.K., Gu J., Dawson M.I., Cao X., Hobbs P.D., Lin B., Chen G., Lu J., Lin F., Xie Z., Fontana J.A., Reed J.C., Zhang X. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 2000, 289:1159-1164.
95. Lin B., Kolluri S.K., Lin F., Liu W., Han Y.H., Cao X., Dawson M.I., Reed J.C., Zhang X.K. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 2004, 116:527-540.
96. Xue D., Horvitz H.R. Caenorhabditis elegans CED-9 protein is a bifunctional cell-death inhibitor. Nature 1997, 390:305-308.
97. Colussi P.A., Quinn L.M., Huang D.C., Coombe M., Read S.H., Richardson H., Kumar S. Debcl, a proapoptotic Bcl-2 homologue, is a component of the Drosophila melanogaster cell death machinery. J. Cell Biol. 2000, 148:703-714.
98. Igaki T., Kanuka H., Inohara N., Sawamoto K., Nunez G., Okano H., Miura M. Drob-1, a Drosophila member of the Bcl-2/CED-9 family that promotes cell death. Proc. Natl Acad. Sci. USA 2000, 97:662-667.
99. Blagosklonny M.V. Unwinding the loop of Bcl-2 phosphorylation. Leukemia 2001, 15:869-874.
100. Cheng E.H., Kirsch D.G., Clem R.J., Ravi R., Kastan M.B., Bedi A., Ueno K., Hardwick J.M. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 1997, 278:1966-1968.
101. Grandgirard D., Studer E., Monney L., Belser T., Fellay I., Borner C., Michel M.R. Alphaviruses induce apoptosis in Bcl-2-overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2. EMBO J. 1998, 17:1268-1278.
102. Kolluri S.K., Zhu X., Zhou X., Lin B., Chen Y., Sun K., Tian X., Town J., Cao X., Lin F., Zhai D., Kitada S., Luciano F., O'Donnell E., Cao Y., He F., Lin J., Reed J.C., Satterthwait A.C., Zhang X.K. A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. Cancer Cell 2008, 14:285-298.
103. Vignali M., Workman J.L. Location and function of linker histones. Nat. Struct. Biol. 1998, 5:1025-1028.
104. Konishi A., Shimizu S., Hirota J., Takao T., Fan Y., Matsuoka Y., Zhang L., Yoneda Y., Fujii Y., Skoultchi A.I., Tsujimoto Y. Involvement of histone H1.2 in apoptosis induced by DNA double-strand breaks. Cell 2003, 114:673-688.
105. Okamura H., Yoshida K., Amorim B.R., Haneji T. Histone H1.2 is translocated to mitochondria and associates with Bak in bleomycin-induced apoptotic cells. J. Cell. Biochem. 2008, 103:1488-1496.
106. Gine E., Crespo M., Muntanola A., Calpe E., Baptista M.J., Villamor N., Montserrat E., Bosch F. Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment. Haematologica 2008, 93:75-82.
107. Ruiz-Vela A., Korsmeyer S.J. Proapoptotic histone H1.2 induces CASP-3 and -7 activation by forming a protein complex with CYT c, APAF-1 and CASP-9. FEBS Lett. 2007, 581:3422-3428.
108. Grisendi S., Mecucci C., Falini B., Pandolfi P.P. Nucleophosmin and cancer. Nat. Rev. Cancer 2006, 6:493-505.
109. Kerr L.E., Birse-Archbold J.L., Short D.M., McGregor A.L., Heron I., Macdonald D.C., Thompson J., Carlson G.J., Kelly J.S., McCulloch J., Sharkey J. Nucleophosmin is a novel Bax chaperone that regulates apoptotic cell death. Oncogene 2007, 26:2554-2562.
110. Park K.S., Han B.G., Lee K.H., Kim D.S., Kim J.M., Jeon H., Kim H.S., Suh S.W., Lee E.H., Kim S.Y., Lee B.I. Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells. Cancer Lett. 2009, 274:201-207.
111. Lee H.Z., Wu C.H., Chang S.P. Release of nucleophosmin from the nucleus: Involvement in aloe-emodin-induced human lung non small carcinoma cell apoptosis. Int. J. Cancer 2005, 113:971-976.
112. Thompson J., Finlayson K., Salvo-Chirnside E., MacDonald D., McCulloch J., Kerr L., Sharkey J. Characterisation of the Bax-nucleophosmin interaction: the importance of the Bax C-terminus. Apoptosis 2008, 13:394-403.
113. Wang Y., Dawson V.L., Dawson T.M. Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos. Exp. Neurol. 2009, 218:193-202.
114. Yu S.W., Andrabi S.A., Wang H., Kim N.S., Poirier G.G., Dawson T.M., Dawson V.L. Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death. Proc. Natl Acad. Sci. USA 2006, 103:18314-18319.
115. Andrabi S.A., Kim N.S., Yu S.W., Wang H., Koh D.W., Sasaki M., Klaus J.A., Otsuka T., Zhang Z., Koehler R.C., Hurn P.D., Poirier G.G., Dawson V.L., Dawson T.M. Poly(ADP-ribose) (PAR) polymer is a death signal. Proc. Natl Acad. Sci. USA 2006, 103:18308-18313.
116. Merkwirth C., Dargazanli S., Tatsuta T., Geimer S., Lower B., Wunderlich F.T., von Kleist-Retzow J.C., Waisman A., Westermann B., Langer T. Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev. 2008, 22:476-488.
117. Osman C., Merkwirth C., Langer T. Prohibitins and the functional compartmentalization of mitochondrial membranes. J. Cell Sci. 2009, 122:3823-3830.
118. Merkwirth C., Langer T. Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis. Biochim. Biophys. Acta 2009, 1793:27-32.
119. Fusaro G., Dasgupta P., Rastogi S., Joshi B., Chellappan S. Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J. Biol. Chem. 2003, 278:47853-47861.
120. Rastogi S., Joshi B., Fusaro G., Chellappan S. Camptothecin induces nuclear export of prohibitin preferentially in transformed cells through a CRM-1-dependent mechanism. J. Biol. Chem. 2006, 281:2951-2959.
121. Paroni G., Henderson C., Schneider C., Brancolini C. Caspase-2 can trigger cytochrome c release and apoptosis from the nucleus. J. Biol. Chem. 2002, 277:15147-15161.
122. Barrett L.E., Van Bockstaele E.J., Sul J.Y., Takano H., Haydon P.G., Eberwine J.H. Elk-1 associates with the mitochondrial permeability transition pore complex in neurons. Proc. Natl Acad. Sci. USA 2006, 103:5155-5160.
123. Frossi B., Tell G., Spessotto P., Colombatti A., Vitale G., Pucillo C. H(2)O(2) induces translocation of APE/Ref-1 to mitochondria in the Raji B-cell line. J. Cell. Physiol. 2002, 193:180-186.
124. Milovic-Holm K., Krieghoff E., Jensen K., Will H., Hofmann T.G. FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies. EMBO J. 2007, 26:391-401.
125. Brohawn S.G., Partridge J.R., Whittle J.R., Schwartz T.U. The nuclear pore complex has entered the atomic age. Structure 2009, 17:1156-1168.
126. Xylourgidis N., Fornerod M. Acting out of character: regulatory roles of nuclear pore complex proteins. Dev. Cell 2009, 17:617-625.
127. Cook A.G., Conti E. Nuclear export complexes in the frame. Curr. Opin. Struct. Biol. 2010, 20:247-252.
128. Fahrenkrog B. The nuclear pore complex, nuclear transport, and apoptosis. Can. J. Physiol. Pharmacol. 2006, 84:279-286.
129. Behrens P., Brinkmann U., Wellmann A. CSE1L/CAS: its role in proliferation and apoptosis. Apoptosis 2003, 8:39-44.
130. Shaulsky G., Goldfinger N., Ben-Ze'ev A., Rotter V. Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol. Cell. Biol. 1990, 10:6565-6577.
131. Stommel J.M., Marchenko N.D., Jimenez G.S., Moll U.M., Hope T.J., Wahl G.M. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 1999, 18:1660-1672.
132. Zhang Y., Xiong Y. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science 2001, 292:1910-1915.
133. Liang S.H., Clarke M.F. Regulation of p53 localization. Eur. J. Biochem. 2001, 268:2779-2783.
134. Marchenko N.D., Hanel W., Li D., Becker K., Reich N., Moll U.M. Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-alpha3 binding. Cell Death Differ. 2010, 17:255-267.
135. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387:296-299.
136. Grossman S.R., Deato M.E., Brignone C., Chan H.M., Kung A.L., Tagami H., Nakatani Y., Livingston D.M. Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 2003, 300:342-344.
137. Li M., Brooks C.L., Wu-Baer F., Chen D., Baer R., Gu W. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 2003, 302:1972-1975.
138. Brooks C.L., Gu W. p53 ubiquitination: Mdm2 and beyond. Mol. Cell 2006, 21:307-315.
139. Carter S., Bischof O., Dejean A., Vousden K.H. C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat. Cell Biol. 2007, 9:428-435.
140. Freedman D.A., Levine A.J. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell. Biol. 1998, 18:7288-7293.
141. Gottifredi V., Prives C. Molecular biology. Getting p53 out of the nucleus. Science 2001, 292:1851-1852.
142. Lohrum M.A., Woods D.B., Ludwig R.L., Balint E., Vousden K.H. C-terminal ubiquitination of p53 contributes to nuclear export. Mol. Cell. Biol. 2001, 21:8521-8532.
143. Wesierska-Gadek J., Wojciechowski J., Schmid G. Phosphorylation regulates the interaction and complex formation between wt p53 protein and PARP-1. J. Cell. Biochem. 2003, 89:1260-1284.
144. Wesierska-Gadek J., Wojciechowski J., Schmid G. Central and carboxy-terminal regions of human p53 protein are essential for interaction and complex formation with PARP-1. J. Cell. Biochem. 2003, 89:220-232.
145. Valenzuela M.T., Guerrero R., Nunez M.I., Ruiz De Almodovar J.M., Sarker M., de Murcia G., Oliver F.J. PARP-1 modifies the effectiveness of p53-mediated DNA damage response. Oncogene 2002, 21:1108-1116.
146. Li M., Luo J., Brooks C.L., Gu W. Acetylation of p53 inhibits its ubiquitination by Mdm2. J. Biol. Chem. 2002, 277:50607-50611.
147. Kawaguchi Y., Ito A., Appella E., Yao T.P. Charge modification at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking. J. Biol. Chem. 2006, 281:1394-1400.
148. Sykes S.M., Stanek T.J., Frank A., Murphy M.E., McMahon S.B. Acetylation of the DNA binding domain regulates transcription-independent apoptosis by p53. J. Biol. Chem. 2009, 284:20197-20205.
149. Han M.K., Song E.K., Guo Y., Ou X., Mantel C., Broxmeyer H.E. SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2008, 2:241-251.
150. Cho S.D., Yoon K., Chintharlapalli S., Abdelrahim M., Lei P., Hamilton S., Khan S., Ramaiah S.K., Safe S. Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways. Cancer Res. 2007, 67:674-683.
151. No H., Bang Y., Lim J., Kim S.S., Choi H.S., Choi H.J. Involvement of induction and mitochondrial targeting of orphan nuclear receptor Nur77 in 6-OHDA-induced SH-SY5Y cell death. Neurochem. Int. 2010, 56:620-626.
152. Lin X.F., Zhao B.X., Chen H.Z., Ye X.F., Yang C.Y., Zhou H.Y., Zhang M.Q., Lin S.C., Wu Q. RXRalpha acts as a carrier for TR3 nuclear export in a 9-cis retinoic acid-dependent manner in gastric cancer cells. J. Cell Sci. 2004, 117:5609-5621.
153. Davis I.J., Hazel T.G., Chen R.H., Blenis J., Lau L.F. Functional domains and phosphorylation of the orphan receptor Nur77. Mol. Endocrinol. 1993, 7:953-964.
154. Chen H.Z., Zhao B.X., Zhao W.X., Li L., Zhang B., Wu Q. Akt phosphorylates the TR3 orphan receptor and blocks its targeting to the mitochondria. Carcinogenesis 2008, 29:2078-2088.
155. Chen L., Hu L., Chan T.H., Tsao G.S., Xie D., Huo K.K., Fu L., Ma S., Zheng B.J., Guan X.Y. Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival. Hepatology 2009, 50:122-129.
156. Lee J.M., Lee K.H., Weidner M., Osborne B.A., Hayward S.D. Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis. Proc. Natl Acad. Sci. USA 2002, 99:11878-11883.
157. Gillespie D.A., Vousden K.H. The secret life of histones. Cell 2003, 114:655-656.
158. Wang W., Budhu A., Forgues M., Wang X.W. Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication. Nat. Cell Biol. 2005, 7:823-830.
159. Falini B., Nicoletti I., Martelli M.F., Mecucci C. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+AML): biologic and clinical features. Blood 2007, 109:874-885.
160. Bano D., Dinsdale D., Cabrera-Socorro A., Maida S., Lambacher N., McColl B., Ferrando-May E., Hengartner M.O., Nicotera P. Alteration of the nuclear pore complex in Ca(2+)-mediated cell death. Cell Death Differ. 2010, 17:119-133.
161. Wyllie A.H., Kerr J.F., Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 1980, 68:251-306.
162. Potten C.S. Perspectives on Mammalian Cell Death, Ultrastructural Aspect of Cell Death 1987, Oxford University Press, Oxford.
163. Kodiha M., Chu A., Matusiewicz N., Stochaj U. Multiple mechanisms promote the inhibition of classical nuclear import upon exposure to severe oxidative stress. Cell Death Differ. 2004, 11:862-874.
164. 2+ store. Science 1995, 270:1835-1838.
165. Erickson E.S., Mooren O.L., Moore D., Krogmeier J.R., Dunn R.C. The role of nuclear envelope calcium in modifying nuclear pore complex structure. Can. J. Physiol. Pharmacol. 2006, 84:309-318.
166. 2+. J. Cell. Biochem. 2006, 97:233-243.
167. Kihlmark M., Imreh G., Hallberg E. Sequential degradation of proteins from the nuclear envelope during apoptosis. J. Cell Sci. 2001, 114:3643-3653.
168. Kihlmark M., Rustum C., Eriksson C., Beckman M., Iverfeldt K., Hallberg E. Correlation between nucleocytoplasmic transport and caspase-3-dependent dismantling of nuclear pores during apoptosis. Exp. Cell Res. 2004, 293:346-356.
169. Patre M., Tabbert A., Hermann D., Walczak H., Rackwitz H.R., Cordes V.C., Ferrando-May E. Caspases target only two architectural components within the core structure of the nuclear pore complex. J. Biol. Chem. 2006, 281:1296-1304.
170. Buendia B., Santa-Maria A., Courvalin J.C. Caspase-dependent proteolysis of integral and peripheral proteins of nuclear membranes and nuclear pore complex proteins during apoptosis. J. Cell Sci. 1999, 112(Pt 11):1743-1753.
171. Kramer A., Liashkovich I., Oberleithner H., Ludwig S., Mazur I., Shahin V. Apoptosis leads to a degradation of vital components of active nuclear transport and a dissociation of the nuclear lamina. Proc. Natl Acad. Sci. USA 2008, 105:11236-11241.
172. Lazebnik Y.A., Cole S., Cooke C.A., Nelson W.G., Earnshaw W.C. Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis. J. Cell Biol. 1993, 123:7-22.
173. Falcieri E., Gobbi P., Cataldi A., Zamai L., Faenza I., Vitale M. Nuclear pores in the apoptotic cell. Histochem. J. 1994, 26:754-763.
174. Delphin C., Guan T., Melchior F., Gerace L. RanGTP targets p97 to RanBP2, a filamentous protein localized at the cytoplasmic periphery of the nuclear pore complex. Mol. Biol. Cell 1997, 8:2379-2390.
175. Ohtsubo M., Okazaki H., Nishimoto T. The RCC1 protein, a regulator for the onset of chromosome condensation locates in the nucleus and binds to DNA. J. Cell Biol. 1989, 109:1389-1397.
176. Friedman J.R., Fredericks W.J., Jensen D.E., Speicher D.W., Huang X.P., Neilson E.G., Rauscher F.J. KAP-1, a novel corepressor for the highly conserved KRAB repression domain. Genes Dev. 1996, 10:2067-2078.
177. Moosmann P., Georgiev O., Le Douarin B., Bourquin J.P., Schaffner W. Transcriptional repression by RING finger protein TIF1 beta that interacts with the KRAB repressor domain of KOX1. Nucleic Acids Res. 1996, 24:4859-4867.
178. Scorrano L., Oakes S.A., Opferman J.T., Cheng E.H., Sorcinelli M.D., Pozzan T., Korsmeyer S.J. BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 2003, 300:135-139.
179. Mandal M., Adam L., Mendelsohn J., Kumar R. Nuclear targeting of Bax during apoptosis in human colorectal cancer cells. Oncogene 1998, 17:999-1007.
180. Quignon F., De Bels F., Koken M., Feunteun J., Ameisen J.C., de The H. PML induces a novel caspase-independent death process. Nat. Genet. 1998, 20:259-265.
181. Joy A., Panicker S., Shapiro J.R. Altered nuclear localization of bax protein in BCNU-resistant glioma cells. J. Neurooncol. 2000, 49:117-129.
182. Gajkowska B., Wojewodzka U. A novel embedment-free immunoelectron microscopy technique reveals association of apoptosis-regulating proteins with subcellular structures. Histochem. J. 2002, 34:441-446.
183. Gajkowska B., Motyl T., Olszewska-Badarczuk H., Godlewski M.M. Expression of BAX in cell nucleus after experimentally induced apoptosis revealed by immunogold and embedment-free electron microscopy. Cell Biol. Int. 2001, 25:725-733.
184. Bartholomeusz G., Wu Y., Ali Seyed M., Xia W., Kwong K.Y., Hortobagyi G., Hung M.C. Nuclear translocation of the pro-apoptotic Bcl-2 family member Bok induces apoptosis. Mol. Carcinog. 2006, 45:73-83.